AI-generated summary
The authors compared daily repeated low-level red light therapy with 0.01% low-dose atropine eye drops in children aged 7 to 12 over 12 months. They report that 12-month myopia incidence was lower with red light therapy than with atropine, in both the full sample and a propensity-matched subset. The study was a prospective comparative design, not a randomized trial.
- Participants
- 216
- Who or what was studied
- Children aged 7 to 12 years using either repeated low-level red light therapy or 0.01% low-dose atropine eye drops for myopia prevention
- Limits stated in the abstract
- The abstract describes a prospective comparative study, not a randomized design, and relies on propensity matching of only 69 pairs per group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Repeated low-level red light, Myopia, Dose, Red light therapy, Primary outcome, Adverse event. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.